Rani Therapeutics Holdings Inc - Class A —— 季度财务数据 (NASDAQ:RANI) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

经营活动产生的现金 -8.65 M-8.15 M-5.8 M-5.06 M294 K -18.71 M 投资活动产生的现金 2.52 M18.23 M5.71 M0-30.97 M -7.03 M 融资活动产生的现金 5.62 M-3.73 M188 K-1.01 M44.85 M 40.3 M 自由现金流 -8.69 M-8.2 M-5.83 M-5.06 M294 K -18.8 M

新闻

Rani Therapeutics Holdings, Inc. (RANI) Q4 2025 Earnings Call Transcript

Rani Therapeutics任命Alireza Javadi为首席技术官

Rani Therapeutics promotes Alireza Javadi to chief technical officer

Rani Therapeutics begins phase 1 trial of oral obesity treatment

Rani Therapeutics修改公司章程，降低B类股投票权并终止税务协议

Rani Therapeutics amends charter, reduces Class B voting power and ends tax agreement

Rani Therapeutics宣布与中外制药达成价值10.85亿美元合作协议

Rani Therapeutics announces $1.085 billion Chugai collaboration

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.09%

美国股市上涨；截至收盘道琼斯工业平均指数上涨0.09%

Monday’s Insider Moves: Top Buys and Sells in US Stocks on October 27

Rani Therapeutics董事Imran Mir A购入价值126万美元股票